Drugs / Fluorine F 18 Fluoro Furanyl Norprogesterone
Fluorine F 18 Fluoro Furanyl Norprogesterone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06179303 | Jul 2024 → Mar 2027 expected | female breast carcinoma, hormone receptor-positive breast cancer | University of Washington | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluorine F 18 Fluoro Furanyl Norprogesterone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06179303 ↗ |
| Modality | Diagnostic / imaging agent | “FFNP as an imaging agent” NCT06179303 ↗ |
| Route | Intravenous | “Given IV” NCT06179303 ↗ |